Evidence map›Paper›PMID 27440879›Full record

ArticleJournal of virology2016

Viral Macro Domains Reverse Protein ADP-Ribosylation.

Changqing Li, Yannick Debing, Gytis Jankevicius, Johan Neyts, Ivan Ahel, Bruno Coutard, Bruno Canard

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. NADThe Journal of general virology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Biomolecular NMR assignments · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. IFN-bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Mutation of a highly conserved isoleucine residue in loop 2 of severalbioRxiv : the preprint server for biology · 2024
    Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Changqing LiCNRS, AFMB UMR 7257, Marseille, France Aix-Marseille Université, AFMB UMR 7257, Marseille, France.
Yannick DebingRega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, Leuven, Belgium.
Gytis JankeviciusSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Johan NeytsRega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, Leuven, Belgium.
Ivan AhelSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Bruno CoutardCNRS, AFMB UMR 7257, Marseille, France Aix-Marseille Université, AFMB UMR 7257, Marseille, France bruno.coutard@afmb.univ-mrs.fr bruno.canard@afmb.univ-mrs.fr.
Bruno CanardCNRS, AFMB UMR 7257, Marseille, France Aix-Marseille Université, AFMB UMR 7257, Marseille, France bruno.coutard@afmb.univ-mrs.fr bruno.canard@afmb.univ-mrs.fr.
KU Leuven · BEUniversity of Oxford · GBAix-Marseille Université · FRArchitecture et Fonction des Macromolécules Biologiques · FRCentre National de la Recherche Scientifique · FR

Funding

Wellcome Trust
6 · The paper itself

Abstract

unlabelledADP-ribosylation is a posttranslational protein modification in which ADP-ribose is transferred from NAD(+) to specific acceptors to regulate a wide variety of cellular processes. The macro domain is an ancient and highly evolutionarily conserved protein domain widely distributed throughout all kingdoms of life, including viruses. The human TARG1/C6orf130, MacroD1, and MacroD2 proteins can reverse ADP-ribosylation by acting on ADP-ribosylated substrates through the hydrolytic activity of their macro domains. Here, we report that the macro domain from hepatitis E virus (HEV) serves as an ADP-ribose-protein hydrolase for mono-ADP-ribose (MAR) and poly(ADP-ribose) (PAR) chain removal (de-MARylation and de-PARylation, respectively) from mono- and poly(ADP)-ribosylated proteins, respectively. The presence of the HEV helicase in cis dramatically increases the binding of the macro domain to poly(ADP-ribose) and stimulates the de-PARylation activity. Abrogation of the latter dramatically decreases replication of an HEV subgenomic replicon. The de-MARylation activity is present in all three pathogenic positive-sense, single-stranded RNA [(+)ssRNA] virus families which carry a macro domain: Coronaviridae (severe acute respiratory syndrome coronavirus and human coronavirus 229E), Togaviridae (Venezuelan equine encephalitis virus), and Hepeviridae (HEV), indicating that it might be a significant tropism and/or pathogenic determinant. IMPORTANCE: Protein ADP-ribosylation is a covalent posttranslational modification regulating cellular protein activities in a dynamic fashion to modulate and coordinate a variety of cellular processes. Three viral families, Coronaviridae, Togaviridae, and Hepeviridae, possess macro domains embedded in their polyproteins. Here, we show that viral macro domains reverse cellular ADP-ribosylation, potentially cutting the signal of a viral infection in the cell. Various poly(ADP-ribose) polymerases which are notorious guardians of cellular integrity are demodified by macro domains from members of these virus families. In the case of hepatitis E virus, the adjacent viral helicase domain dramatically increases the binding of the macro domain to PAR and simulates the demodification activity.

Indexed as

Protein Processing, Post-TranslationalAdenosine Diphosphate RiboseHepatitis E virusHumansHydrolysisPolyproteinsViral ProteinsAdenosine Diphosphate RibosePolyproteinsViral Proteins

Identifiers

PMID27440879
PMCPMC5021415
OpenAlexW2503176400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.